Sandoz Debuts Aflibercept Biosimilar In Europe

Also Agrees Marketing Deal In Germany For Formycon’s Ranibizumab

 
• By Dave Wallace
  
Sandoz is launching its Eylea rival in Europe (Shutterstock)

More from Biosimilars

More from Products